438 related articles for article (PubMed ID: 34552932)
1. Glucose Metabolism and Glucose Transporters in Breast Cancer.
Shin E; Koo JS
Front Cell Dev Biol; 2021; 9():728759. PubMed ID: 34552932
[TBL] [Abstract][Full Text] [Related]
2. Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors.
Naik A; Decock J
Front Oncol; 2020; 10():598626. PubMed ID: 33324565
[TBL] [Abstract][Full Text] [Related]
3. Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.
Choi J; Kim DH; Jung WH; Koo JS
Breast Cancer Res; 2013; 15(5):R78. PubMed ID: 24020991
[TBL] [Abstract][Full Text] [Related]
4. Metabolic phenotypes in triple-negative breast cancer.
Kim S; Kim DH; Jung WH; Koo JS
Tumour Biol; 2013 Jun; 34(3):1699-712. PubMed ID: 23443971
[TBL] [Abstract][Full Text] [Related]
5. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.
Brauer HA; Makowski L; Hoadley KA; Casbas-Hernandez P; Lang LJ; Romàn-Pèrez E; D'Arcy M; Freemerman AJ; Perou CM; Troester MA
Clin Cancer Res; 2013 Feb; 19(3):571-85. PubMed ID: 23236214
[TBL] [Abstract][Full Text] [Related]
8. Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds.
Barbosa AM; Martel F
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936350
[TBL] [Abstract][Full Text] [Related]
9. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer.
Varghese E; Samuel SM; Líšková A; Samec M; Kubatka P; Büsselberg D
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806533
[TBL] [Abstract][Full Text] [Related]
11. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer.
Delgir S; Bastami M; Ilkhani K; Safi A; Seif F; Alivand MR
Mutat Res Rev Mutat Res; 2021; 787():108366. PubMed ID: 34083056
[TBL] [Abstract][Full Text] [Related]
12. The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities.
Ghanem N; El-Baba C; Araji K; El-Khoury R; Usta J; Darwiche N
Chemotherapy; 2021; 66(5-6):179-191. PubMed ID: 34775382
[TBL] [Abstract][Full Text] [Related]
13. Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer.
Ghergurovich JM; Lang JD; Levin MK; Briones N; Facista SJ; Mueller C; Cowan AJ; McBride MJ; Rodriguez ESR; Killian A; Dao T; Lamont J; Barron A; Su X; Hendricks WPD; Espina V; Von Hoff DD; O'Shaughnessy J; Rabinowitz JD
Med; 2021 Jun; 2(6):736-754. PubMed ID: 34223403
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue.
Sotgia F; Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Philp NJ; Pestell RG; Lisanti MP
Cell Cycle; 2012 Apr; 11(7):1445-54. PubMed ID: 22395432
[TBL] [Abstract][Full Text] [Related]
15. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.
Ghashghaeinia M; Köberle M; Mrowietz U; Bernhardt I
Cell Cycle; 2019 Jun; 18(12):1316-1334. PubMed ID: 31154896
[TBL] [Abstract][Full Text] [Related]
16. Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.
Cha YJ; Kim ES; Koo JS
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562706
[TBL] [Abstract][Full Text] [Related]
17. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling.
Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M
EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198
[TBL] [Abstract][Full Text] [Related]
18. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the Warburg effect and progression of triple-negative breast cancer.
Liu S; Li Y; Yuan M; Song Q; Liu M
Front Oncol; 2022; 12():1060495. PubMed ID: 36776368
[TBL] [Abstract][Full Text] [Related]
20. The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway.
Jacquier V; Gitenay D; Cavaillès V; Teyssier C
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
